Table 1.
Control | Dapagliflozin | HFD/STZ | HFD/STZ/dapa | |
---|---|---|---|---|
Blood glucose, mg/dl | 100 ± 7 | 99 ± 7 | 205 ± 118 | 130 ± 31 |
Body weight, g | 430 ± 23 | 430 ± 22 | 424 ± 44 | 421 ± 20 |
Bladder weight, mg | 161 ± 33 | 183 ± 18 | 175 ± 46 | 192 ± 11 |
Bladder/body weight, g/100 g | 0.30 ± 0.16 | 0.43 ± 0.04 | 0.43 ± 0.15 | 0.46 ± 0.04 |
Data are means ± SD of 10 rats, except for HFD/STZ group (n = 9) as based on the last measurement before study end. Bladder weight did not differ significantly between HFD/STZ and control animals (null hypothesis rejected). Note that some values differ from the last data point in Figure 1 because end-of-study measurement was not in the same week for all rats.